A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
National Institutes of Health Clinical Center (CC)
ViroMissile, Inc.
Angiex, Inc.
MacroGenics
City of Hope Medical Center
Degron Therapeutics Co.
Bristol-Myers Squibb
Actym Therapeutics, Inc.
City of Hope Medical Center
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
NextPoint Therapeutics, Inc.
ADC Therapeutics S.A.
National Cancer Institute (NCI)
Shanghai PerHum Therapeutics Co., Ltd.
Xencor, Inc.
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
Emory University
Tempest Therapeutics
Sorrento Therapeutics, Inc.
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
MacroGenics
Tocagen Inc.
TG Therapeutics, Inc.
Pfizer
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Altor BioScience
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
NYU Langone Health
Mannkind Corporation
Case Comprehensive Cancer Center